195 related articles for article (PubMed ID: 26996668)
1. The presence of C/EBPα and its degradation are both required for TRIB2-mediated leukaemia.
O'Connor C; Lohan F; Campos J; Ohlsson E; Salomè M; Forde C; Artschwager R; Liskamp RM; Cahill MR; Kiely PA; Porse B; Keeshan K
Oncogene; 2016 Oct; 35(40):5272-5281. PubMed ID: 26996668
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Trib2 by an E2F1-C/EBPα feedback loop in AML cell proliferation.
Rishi L; Hannon M; Salomè M; Hasemann M; Frank AK; Campos J; Timoney J; O'Connor C; Cahill MR; Porse B; Keeshan K
Blood; 2014 Apr; 123(15):2389-400. PubMed ID: 24516045
[TBL] [Abstract][Full Text] [Related]
3. C/EBPα-p30 confers AML cell susceptibility to the terminal unfolded protein response and resistance to Venetoclax by activating DDIT3 transcription.
Du M; Wang M; Liu M; Fu S; Lin Y; Huo Y; Yu J; Yu X; Wang C; Xiao H; Wang L
J Exp Clin Cancer Res; 2024 Mar; 43(1):79. PubMed ID: 38475919
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia.
Grebien F; Vedadi M; Getlik M; Giambruno R; Grover A; Avellino R; Skucha A; Vittori S; Kuznetsova E; Smil D; Barsyte-Lovejoy D; Li F; Poda G; Schapira M; Wu H; Dong A; Senisterra G; Stukalov A; Huber KVM; Schönegger A; Marcellus R; Bilban M; Bock C; Brown PJ; Zuber J; Bennett KL; Al-Awar R; Delwel R; Nerlov C; Arrowsmith CH; Superti-Furga G
Nat Chem Biol; 2015 Aug; 11(8):571-578. PubMed ID: 26167872
[TBL] [Abstract][Full Text] [Related]
5. TRIB2 and the ubiquitin proteasome system in cancer.
Salomè M; Campos J; Keeshan K
Biochem Soc Trans; 2015 Oct; 43(5):1089-94. PubMed ID: 26517929
[TBL] [Abstract][Full Text] [Related]
6. Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia.
Keeshan K; He Y; Wouters BJ; Shestova O; Xu L; Sai H; Rodriguez CG; Maillard I; Tobias JW; Valk P; Carroll M; Aster JC; Delwel R; Pear WS
Cancer Cell; 2006 Nov; 10(5):401-11. PubMed ID: 17097562
[TBL] [Abstract][Full Text] [Related]
7. Homodimer-mediated phosphorylation of C/EBPα-p42 S16 modulates acute myeloid leukaemia differentiation through liquid-liquid phase separation.
Wang D; Sun T; Xia Y; Zhao Z; Sheng X; Li S; Ma Y; Li M; Su X; Zhang F; Li P; Ma D; Ye J; Lu F; Ji C
Nat Commun; 2023 Oct; 14(1):6907. PubMed ID: 37903757
[TBL] [Abstract][Full Text] [Related]
8. Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells.
Wang L; Xiao H; Zhang X; Liao W; Fu S; Huang H
Int J Oncol; 2015 Nov; 47(5):1685-95. PubMed ID: 26397153
[TBL] [Abstract][Full Text] [Related]
9. E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradation.
Pal P; Lochab S; Kanaujiya JK; Kapoor I; Sanyal S; Behre G; Trivedi AK
Cell Death Dis; 2013 Apr; 4(4):e590. PubMed ID: 23598402
[TBL] [Abstract][Full Text] [Related]
10. C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia.
Hughes JM; Legnini I; Salvatori B; Masciarelli S; Marchioni M; Fazi F; Morlando M; Bozzoni I; Fatica A
Oncotarget; 2015 Jul; 6(21):18534-44. PubMed ID: 26053097
[TBL] [Abstract][Full Text] [Related]
11. CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex.
Schmidt L; Heyes E; Scheiblecker L; Eder T; Volpe G; Frampton J; Nerlov C; Valent P; Grembecka J; Grebien F
Leukemia; 2019 Jul; 33(7):1608-1619. PubMed ID: 30679799
[TBL] [Abstract][Full Text] [Related]
12. C/EBPα in normal and malignant myelopoiesis.
Friedman AD
Int J Hematol; 2015 Apr; 101(4):330-41. PubMed ID: 25753223
[TBL] [Abstract][Full Text] [Related]
13. Elevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in AML.
Pulikkan JA; Dengler V; Peer Zada AA; Kawasaki A; Geletu M; Pasalic Z; Bohlander SK; Ryo A; Tenen DG; Behre G
Leukemia; 2010 May; 24(5):914-23. PubMed ID: 20376080
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of TRIB2 in human lung cancers contributes to tumorigenesis through downregulation of C/EBPα.
Grandinetti KB; Stevens TA; Ha S; Salamone RJ; Walker JR; Zhang J; Agarwalla S; Tenen DG; Peters EC; Reddy VA
Oncogene; 2011 Jul; 30(30):3328-35. PubMed ID: 21399661
[TBL] [Abstract][Full Text] [Related]
15. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.
Asou H; Gombart AF; Takeuchi S; Tanaka H; Tanioka M; Matsui H; Kimura A; Inaba T; Koeffler HP
Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245
[TBL] [Abstract][Full Text] [Related]
16.
Liu M; Du M; Yu J; Qian Z; Gao Y; Pan W; Zhao X; Wang M; Li H; Zheng J; Huang Q; Wang LM; Xiao H
Oncoimmunology; 2022; 11(1):2016158. PubMed ID: 35003895
[TBL] [Abstract][Full Text] [Related]
17. Ring finger protein 138 inhibits transcription factor C/EBPα protein turnover leading to differentiation arrest in acute myeloid leukemia.
Singh AK; Upadhyay V; Sethi A; Chowdhury S; Mishra S; Verma SP; Bhatt MLB; Trivedi AK
Biochem J; 2024 May; 481(10):653-666. PubMed ID: 38666590
[TBL] [Abstract][Full Text] [Related]
18. Inverse and correlative relationships between TRIBBLES genes indicate non-redundant functions during normal and malignant hemopoiesis.
Salomé M; Hopcroft L; Keeshan K
Exp Hematol; 2018 Oct; 66():63-78.e13. PubMed ID: 30031847
[TBL] [Abstract][Full Text] [Related]
19. Differential ability of Tribbles family members to promote degradation of C/EBPalpha and induce acute myelogenous leukemia.
Dedhia PH; Keeshan K; Uljon S; Xu L; Vega ME; Shestova O; Zaks-Zilberman M; Romany C; Blacklow SC; Pear WS
Blood; 2010 Aug; 116(8):1321-8. PubMed ID: 20410507
[TBL] [Abstract][Full Text] [Related]
20. A C-terminal mutant of CCAAT-enhancer-binding protein α (C/EBPα-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPα-Cm.
Togami K; Kitaura J; Uchida T; Inoue D; Nishimura K; Kawabata KC; Nagase R; Horikawa S; Izawa K; Fukuyama T; Nakahara F; Oki T; Harada Y; Harada H; Aburatani H; Kitamura T
Exp Hematol; 2015 Apr; 43(4):300-8.e1. PubMed ID: 25534203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
